RN7SK pseudogene 184 (RN7SKP184)

RN7SK pseudogene 184 (RN7SKP184) is a processed pseudogene derived from the functional RNA, 7SK small nuclear (RN7SK) gene that encodes a well-studied small nuclear RNA, 7SK[1][3][5]. Unlike the active parental gene, pseudogenes such as RN7SKP184 are not believed to produce functional RNA transcripts or proteins and do not participate in biological processes. The functional RN7SK gene is essential for the negative regulation of transcription elongation by RNA polymerase II, and acts as an RNA scaffold for the 7SK snRNP complex that controls P-TEFb kinase activity[1][2][3][4][6]. Dysregulation of RN7SK is implicated in diverse diseases including certain cancers, heart disease, and viral infections[2][3][4][6]. Key Issues and Clarifications - The "pseudogene" status means RN7SKP184 is not an active biological target, receptor, or enzyme. - Not found in standard lists of drug targets or pathological biomarkers, nor does it have known roles in disease or drug interaction[3][5]. - Some confusion may arise from similarity to the canonical RN7SK, which plays a significant role in transcription control, cell cycle, and differentiation[2][4][6], but pseudogenes rarely retain such functions. Conclusion: RN7SKP184 is a pseudogene and not a receptor, enzyme, or therapeutic target. If searching for drug targets or functional biological roles, use the canonical RNA, 7SK small nuclear (RN7SK) gene rather than any pseudogene variant like RN7SKP184[1][3][5].

Other names

RN7SKP1847SK pseudogene 184